Cytochrome P-450 CYP2C9 Inducers (moderate)
- Name
- Cytochrome P-450 CYP2C9 Inducers (moderate)
- Accession Number
- DBCAT003109
- Description
Not Available
- Drugs
Drug Drug Description Bosentan A dual endothelin receptor antagonist used to treat pulmonary arterial hypertension. Enzalutamide A second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. Alpelisib Alpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor... Rifampin An antibiotic used alone or in combination with other antimicrobial drugs to treat tuberculosis and asymptomatic carriers of Neisseria meningitidis. - Drugs & Drug Targets